Interleukin-2 Plus Ribavirin Versus Interferon-??-2b Plus Ribavirin in Patients with Chronic Hepatitis C Who Did Not Respond to Previous Interferon-??-2b Treatment

Interleukin-2 Plus Ribavirin Versus Interferon-??-2b Plus Ribavirin in Patients with Chronic Hepatitis C Who Did Not Respond to Previous Interferon-??-2b Treatment

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy biopharmaceuticals, and gene therapy, 2004, Vol.18 (6), p.407-413
Hauptverfasser: Malaguarnera, Mariano, Pistone, Giovanni, Neri, Sergio, Romano, Marcello, Brogna, Alfio, Musumeci, Salvatore
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 413
container_issue 6
container_start_page 407
container_title BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy
container_volume 18
creator Malaguarnera, Mariano
Pistone, Giovanni
Neri, Sergio
Romano, Marcello
Brogna, Alfio
Musumeci, Salvatore
description
doi_str_mv 10.2165/00063030-200418060-00006
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_2165_00063030_200418060_00006</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_2165_00063030_200418060_00006</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1046-9690a387ff97dea78b8effa4488aaf2897d1998eda5836e6e0aa29df30f4a0e03</originalsourceid><addsrcrecordid>eNptkNtKAzEQQPOgYK3-Q34gOtlss8lTkfXSQtFSqj4uaXdCo-2mJGnF7_FH3a6XBxEGBg6HGTiEUA4XGZeDSwCQAgSwDCDnCiQwOLAj0uO8EEwpyE_IaYwvnamLHvkYNwnDGnevrmEZna53kc7cwuxdcA19whBb0DkWg2_YcMiyxV-tnalJDpsU6ZtLK1quWtct6Qi3LU8u0pI-rzy9djW994nOMG59U9Pk6TTg3vn_nswDmrRpj56RY2vWEc-_d5883t7MyxGbPNyNy6sJW3LIJdNSgxGqsFYXNZpCLRRaa_JcKWNsplrKtVZYm4ESEiWCMZmurQCbG0AQfaK-7i6DjzGgrbbBbUx4rzhUh8DVT-DqN3DVBRafRVhyTw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Interleukin-2 Plus Ribavirin Versus Interferon-??-2b Plus Ribavirin in Patients with Chronic Hepatitis C Who Did Not Respond to Previous Interferon-??-2b Treatment</title><source>SpringerLink Journals</source><creator>Malaguarnera, Mariano ; Pistone, Giovanni ; Neri, Sergio ; Romano, Marcello ; Brogna, Alfio ; Musumeci, Salvatore</creator><creatorcontrib>Malaguarnera, Mariano ; Pistone, Giovanni ; Neri, Sergio ; Romano, Marcello ; Brogna, Alfio ; Musumeci, Salvatore</creatorcontrib><identifier>ISSN: 1173-8804</identifier><identifier>DOI: 10.2165/00063030-200418060-00006</identifier><language>eng</language><ispartof>BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2004, Vol.18 (6), p.407-413</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1046-9690a387ff97dea78b8effa4488aaf2897d1998eda5836e6e0aa29df30f4a0e03</citedby><cites>FETCH-LOGICAL-c1046-9690a387ff97dea78b8effa4488aaf2897d1998eda5836e6e0aa29df30f4a0e03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids></links><search><creatorcontrib>Malaguarnera, Mariano</creatorcontrib><creatorcontrib>Pistone, Giovanni</creatorcontrib><creatorcontrib>Neri, Sergio</creatorcontrib><creatorcontrib>Romano, Marcello</creatorcontrib><creatorcontrib>Brogna, Alfio</creatorcontrib><creatorcontrib>Musumeci, Salvatore</creatorcontrib><title>Interleukin-2 Plus Ribavirin Versus Interferon-??-2b Plus Ribavirin in Patients with Chronic Hepatitis C Who Did Not Respond to Previous Interferon-??-2b Treatment</title><title>BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy</title><issn>1173-8804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNptkNtKAzEQQPOgYK3-Q34gOtlss8lTkfXSQtFSqj4uaXdCo-2mJGnF7_FH3a6XBxEGBg6HGTiEUA4XGZeDSwCQAgSwDCDnCiQwOLAj0uO8EEwpyE_IaYwvnamLHvkYNwnDGnevrmEZna53kc7cwuxdcA19whBb0DkWg2_YcMiyxV-tnalJDpsU6ZtLK1quWtct6Qi3LU8u0pI-rzy9djW994nOMG59U9Pk6TTg3vn_nswDmrRpj56RY2vWEc-_d5883t7MyxGbPNyNy6sJW3LIJdNSgxGqsFYXNZpCLRRaa_JcKWNsplrKtVZYm4ESEiWCMZmurQCbG0AQfaK-7i6DjzGgrbbBbUx4rzhUh8DVT-DqN3DVBRafRVhyTw</recordid><startdate>2004</startdate><enddate>2004</enddate><creator>Malaguarnera, Mariano</creator><creator>Pistone, Giovanni</creator><creator>Neri, Sergio</creator><creator>Romano, Marcello</creator><creator>Brogna, Alfio</creator><creator>Musumeci, Salvatore</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>2004</creationdate><title>Interleukin-2 Plus Ribavirin Versus Interferon-??-2b Plus Ribavirin in Patients with Chronic Hepatitis C Who Did Not Respond to Previous Interferon-??-2b Treatment</title><author>Malaguarnera, Mariano ; Pistone, Giovanni ; Neri, Sergio ; Romano, Marcello ; Brogna, Alfio ; Musumeci, Salvatore</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1046-9690a387ff97dea78b8effa4488aaf2897d1998eda5836e6e0aa29df30f4a0e03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Malaguarnera, Mariano</creatorcontrib><creatorcontrib>Pistone, Giovanni</creatorcontrib><creatorcontrib>Neri, Sergio</creatorcontrib><creatorcontrib>Romano, Marcello</creatorcontrib><creatorcontrib>Brogna, Alfio</creatorcontrib><creatorcontrib>Musumeci, Salvatore</creatorcontrib><collection>CrossRef</collection><jtitle>BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Malaguarnera, Mariano</au><au>Pistone, Giovanni</au><au>Neri, Sergio</au><au>Romano, Marcello</au><au>Brogna, Alfio</au><au>Musumeci, Salvatore</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interleukin-2 Plus Ribavirin Versus Interferon-??-2b Plus Ribavirin in Patients with Chronic Hepatitis C Who Did Not Respond to Previous Interferon-??-2b Treatment</atitle><jtitle>BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy</jtitle><date>2004</date><risdate>2004</risdate><volume>18</volume><issue>6</issue><spage>407</spage><epage>413</epage><pages>407-413</pages><issn>1173-8804</issn><doi>10.2165/00063030-200418060-00006</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1173-8804
ispartof BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2004, Vol.18 (6), p.407-413
issn 1173-8804
language eng
recordid cdi_crossref_primary_10_2165_00063030_200418060_00006
source SpringerLink Journals
title Interleukin-2 Plus Ribavirin Versus Interferon-??-2b Plus Ribavirin in Patients with Chronic Hepatitis C Who Did Not Respond to Previous Interferon-??-2b Treatment
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T08%3A37%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interleukin-2%20Plus%20Ribavirin%20Versus%20Interferon-??-2b%20Plus%20Ribavirin%20in%20Patients%20with%20Chronic%20Hepatitis%20C%20Who%20Did%20Not%20Respond%20to%20Previous%20Interferon-??-2b%20Treatment&rft.jtitle=BioDrugs%20:%20clinical%20immunotherapeutics,%20biopharmaceuticals,%20and%20gene%20therapy&rft.au=Malaguarnera,%20Mariano&rft.date=2004&rft.volume=18&rft.issue=6&rft.spage=407&rft.epage=413&rft.pages=407-413&rft.issn=1173-8804&rft_id=info:doi/10.2165/00063030-200418060-00006&rft_dat=%3Ccrossref%3E10_2165_00063030_200418060_00006%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true